Literature DB >> 25313131

Biased estimates of diminishing-returns epistasis? Empirical evidence revisited.

David Berger1, Erik Postma2.   

Abstract

Empirical evidence for diminishing fitness returns of beneficial mutations supports Fisher's geometric model. We show that a similar pattern emerges through the phenomenon of regression to the mean and that few studies correct for it. Although biases are often small, regression to the mean has overemphasized diminishing returns and will hamper cross-study comparisons unless corrected for.
Copyright © 2014 by the Genetics Society of America.

Keywords:  Fisher’s geometric model; adaptation; epistasis; fitness landscape; regression to the mean

Mesh:

Year:  2014        PMID: 25313131      PMCID: PMC4256761          DOI: 10.1534/genetics.114.169870

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  26 in total

1.  Heritable variation and evolution under favourable and unfavourable conditions.

Authors: 
Journal:  Trends Ecol Evol       Date:  1999-03       Impact factor: 17.712

Review 2.  Bivariate line-fitting methods for allometry.

Authors:  David I Warton; Ian J Wright; Daniel S Falster; Mark Westoby
Journal:  Biol Rev Camb Philos Soc       Date:  2006-03-30

3.  Distributions of epistasis in microbes fit predictions from a fitness landscape model.

Authors:  Guillaume Martin; Santiago F Elena; Thomas Lenormand
Journal:  Nat Genet       Date:  2007-03-18       Impact factor: 38.330

4.  Correcting for regression to the mean in behavior and ecology.

Authors:  Colleen Kelly; Trevor D Price
Journal:  Am Nat       Date:  2005-10-04       Impact factor: 3.926

5.  Comment on "Additive genetic breeding values correlate with the load of partially deleterious mutations".

Authors:  Erik Postma
Journal:  Science       Date:  2011-09-02       Impact factor: 47.728

6.  Evidence for positive epistasis in HIV-1.

Authors:  Sebastian Bonhoeffer; Colombe Chappey; Neil T Parkin; Jeanette M Whitcomb; Christos J Petropoulos
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

7.  Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region.

Authors:  Jack da Silva; Mia Coetzer; Rebecca Nedellec; Cristina Pastore; Donald E Mosier
Journal:  Genetics       Date:  2010-02-15       Impact factor: 4.562

Review 8.  Adaptive evolution: evaluating empirical support for theoretical predictions.

Authors:  Carrie F Olson-Manning; Maggie R Wagner; Thomas Mitchell-Olds
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

9.  Mapping the fitness landscape of gene expression uncovers the cause of antagonism and sign epistasis between adaptive mutations.

Authors:  Hsin-Hung Chou; Nigel F Delaney; Jeremy A Draghi; Christopher J Marx
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

10.  Genetic incompatibilities are widespread within species.

Authors:  Russell B Corbett-Detig; Jun Zhou; Andrew G Clark; Daniel L Hartl; Julien F Ayroles
Journal:  Nature       Date:  2013-11-06       Impact factor: 49.962

View more
  4 in total

1.  Patterns and Mechanisms of Diminishing Returns from Beneficial Mutations.

Authors:  Xinzhu Wei; Jianzhi Zhang
Journal:  Mol Biol Evol       Date:  2019-05-01       Impact factor: 16.240

2.  Diminishing-returns epistasis among random beneficial mutations in a multicellular fungus.

Authors:  Sijmen Schoustra; Sungmin Hwang; Joachim Krug; J Arjan G M de Visser
Journal:  Proc Biol Sci       Date:  2016-08-31       Impact factor: 5.349

3.  Sex-specific dominance reversal of genetic variation for fitness.

Authors:  Karl Grieshop; Göran Arnqvist
Journal:  PLoS Biol       Date:  2018-12-11       Impact factor: 8.029

4.  Flux, toxicity, and expression costs generate complex genetic interactions in a metabolic pathway.

Authors:  Harry Kemble; Catherine Eisenhauer; Alejandro Couce; Audrey Chapron; Mélanie Magnan; Gregory Gautier; Hervé Le Nagard; Philippe Nghe; Olivier Tenaillon
Journal:  Sci Adv       Date:  2020-06-03       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.